go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Alliance Pharmaceuticals Ireland

Alliance Pharmaceuticals Ireland
United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Telephone: + 44 (0)1249 466966
Fax: +44 (0)1249 466 977
Medical Information e-mail: medinfo@alliancepharma.co.uk


Summary of Product Characteristics last updated on medicines.ie: 14/05/2010
SPC Dermamist

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipients
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Dermamist 10% w/w Dry Skin Spray


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

White Soft Paraffin 10% w/w.

For a full list of excipients, see section 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Cutaneous Spray, solution (cutaneous spray)

A cutaneous spray delivering white soft paraffin as a clear colourless spray by means of a pressurised aerosol.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Treatment of dry skin conditions including pruritus (itching and dryness) of the elderly eczema, and ichthyosis (dry scaly skin).


Go to top of the page
4.2 Posology and method of administration

Adults, children and the elderly:

Shake before use. Bathe or shower for not more than ten minutes.

Pat dry and apply spray without delay. Do not spray on face. Spray from a distance of approximately 8 inches. Spray away from the face and move the can while spraying to achieve a very light coverage of the body. Spray sparingly; over application may cause the skin to feel oily.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

For external use only.

Keep out of reach of children.

Do not spray on face.

Use in a ventilated area.

Avoid inhalation.

Guard against slipping.

Discontinue use if the condition is made worse.

Do not apply to broken skin.

Patients being dispensed or treated with large quantities (> 100g) of any paraffin based product should be advised to regularly change clothing or bedding impregnated with the product and keep away from naked flames as there is a fire hazard.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None.


Go to top of the page
4.6 Pregnancy and lactation

Can be used.


Go to top of the page
4.7 Effects on ability to drive and use machines

Not relevant.


Go to top of the page
4.8 Undesirable effects

Not relevant.


Go to top of the page
4.9 Overdose

None.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Emollients are fats or oils used for their local action on the skin and, occasionally, the mucous membranes. These oleaginous substances, also known as occlusive agents and humectants, are employed as protectives and as agents for softening the skin and rendering it more pliable. White soft paraffin forms an effective occlusive lipid film. The mechanism of action is by occluding water loss from the outer layer of skin.


Go to top of the page
5.2 Pharmacokinetic properties

White soft paraffin exerts its physiological effects by forming an occlusive layer on the surface of the skin. It is effective because it is not subject to absorption or subsequent distribution in the body, excretion or metabolism. Pharmacokinetic particulars are not appropriate in these circumstances.


Go to top of the page
5.3 Preclinical safety data

No relevant pre-clinical data has been generated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Liquid paraffin

Medium chain triglycerides

Butane 40 (butane: isobutane: propane)


Go to top of the page
6.2 Incompatibilities

Not Applicable.


Go to top of the page
6.3 Shelf life

5 years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25oC.

Extremely flammable.

Protect from sunlight and do not expose to temperatures exceeding 50oC.

Do not pierce or burn even when empty.

Do not spray on a naked flame or any incandescent material.

Keep away from sources of ignition – no smoking.


Go to top of the page
6.5 Nature and contents of container

Pressurised aluminium aerosol can. Pack sizes: 50ml, 75ml, 100ml, 125ml, 150ml, 200ml, 250ml, 300ml, 400ml and 500ml.

Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Alliance Pharmaceuticals Limited

Bath Road

Chippenham

Wiltshire SN15 2BB

England


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 943/15/1


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Date of first authorisation: 04 April 1997

Date of last renewal: 04 April 2007


Go to top of the page
10. DATE OF REVISION OF THE TEXT

April 2010



Link to this document from your website:
http://www.medicines.ie/medicine/12240/SPC/Dermamist/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   White Soft Paraffin

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo